DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
DexCom
DXCM
Hutchmed (China)
HCM
New Fortress Energy
NFE
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
EDIT Editas Medicine
- 1.380
- +0.150+12.20%
Close Feb 14 16:00 ET
- 1.380
- 0.0000.00%
Post 20:01 ET
113.92MMarket Cap-0.54P/E (TTM)
1.480High1.240Low8.95MVolume1.240Open1.230Pre Close12.29MTurnover11.57%Turnover RatioLossP/E (Static)82.55MShares11.58052wk High0.65P/B106.70MFloat Cap1.12052wk Low--Dividend TTM77.32MShs Float99.950Historical High--Div YieldTTM19.51%Amplitude1.120Historical Low1.373Avg Price1Lot Size
About Editas Medicine Company
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.
Company Profile
SymbolEDIT
Company NameEditas Medicine
Listing DateFeb 3, 2016
Issue Price16.00
Founded2013
CEODr. Gilmore O’Neill, M.B.
MarketNASDAQ
Employees265
Fiscal Year Ends12-31
Address11 Hurley Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02141
Phone1-617-401-9000
Company Executives
- Name
- Position
- Salary
- Dr. Gilmore O’Neill, M.B.
- Director, Chief Executive Officer and President
- 2.39M
- Erick J. Lucera, C.F.A.
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 2.22M
- Linda Burkly
- Executive Vice President and Chief Scientific Officer
- 1.54M
- Dr. Jessica Hopfield, PhD
- Independent Director
- 231.07K
- Dr. David T. Scadden, M.D.
- Independent Director
- 213.06K
- Andrew J. Hirsch
- Independent Director
- 210.56K
- Bernadette M. Connaughton
- Independent Director
- 215.06K
- Dr. Elliott M. Levy, M.D.
- Independent Director
- 264.88K
